Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 72

1.

A CGH array procedure to detect PAX6 gene structural defects.

Franzoni A, Russo PD, Baldan F, D'Elia AV, Puppin C, Penco S, Damante G.

Mol Cell Probes. 2016 Dec 2. pii: S0890-8508(16)30117-7. doi: 10.1016/j.mcp.2016.12.001. [Epub ahead of print]

PMID:
27919838
2.

New Drugs from Marine Organisms in Alzheimer's Disease.

Russo P, Kisialiou A, Lamonaca P, Moroni R, Prinzi G, Fini M.

Mar Drugs. 2015 Dec 25;14(1):5. doi: 10.3390/md14010005. Review.

3.

Deep sea as a source of novel-anticancer drugs: update on discovery and preclinical/clinical evaluation in a systems medicine perspective.

Russo P, Del Bufalo A, Fini M.

EXCLI J. 2015 Feb 10;14:228-36. doi: 10.17179/excli2015-632. Review.

4.

Effect of Genetic Polymorphisms (SNPs) in CHRNA7 Gene on Response to Acetylcholinesterase Inhibitors (AChEI) in Patients with Alzheimer's Disease.

Russo P, Kisialiou A, Moroni R, Prinzi G, Fini M.

Curr Drug Targets. 2015 Oct 1. [Epub ahead of print]

PMID:
26424395
5.

Novel therapeutic strategy in the management of COPD: a systems medicine approach.

Lococo F, Cesario A, Del Bufalo A, Ciarrocchi A, Prinzi G, Mina M, Bonassi S, Russo P.

Curr Med Chem. 2015;22(32):3655-75. Review.

PMID:
26337103
6.

DNA damage in non-communicable diseases: A clinical and epidemiological perspective.

Milic M, Frustaci A, Del Bufalo A, Sánchez-Alarcón J, Valencia-Quintana R, Russo P, Bonassi S.

Mutat Res. 2015 Jun;776:118-27. doi: 10.1016/j.mrfmmm.2014.11.009. Review.

PMID:
26255943
7.

A systems medicine clinical platform for understanding and managing non- communicable diseases.

Cesario A, Auffray C, Agusti A, Apolone G, Balling R, Barbanti P, Bellia A, Boccia S, Bousquet J, Cardaci V, Cazzola M, Dall'Armi V, Daraselia N, Ros LD, Bufalo AD, Ducci G, Ferri L, Fini M, Fossati C, Gensini G, Granone PM, Kinross J, Lauro D, Cascio GL, Lococo F, Lococo A, Maier D, Marcus F, Margaritora S, Marra C, Minati G, Neri M, Pasqua F, Pison C, Pristipino C, Roca J, Rosano G, Rossini PM, Russo P, Salinaro G, Shenhar S, Soreq H, Sterk PJ, Stocchi F, Torti M, Volterrani M, Wouters EF, Frustaci A, Bonassi S.

Curr Pharm Des. 2014;20(38):5945-56. Review.

PMID:
24641232
8.

P4 medicine needs P4 education.

Cesario A, Auffray C, Russo P, Hood L.

Curr Pharm Des. 2014;20(38):6071-2. Review.

PMID:
24641231
9.

Alpha9 alpha10 nicotinic acetylcholine receptors as target for the treatment of chronic pain.

Del Bufalo A, Cesario A, Salinaro G, Fini M, Russo P.

Curr Pharm Des. 2014;20(38):6042-7. Review.

PMID:
24641230
10.

Beyond acetylcholinesterase inhibitors for treating Alzheimer's disease: α7-nAChR agonists in human clinical trials.

Russo P, Del Bufalo A, Frustaci A, Fini M, Cesario A.

Curr Pharm Des. 2014;20(38):6014-21. Review.

PMID:
24641224
11.

Disease control and active and healthy ageing: new paradigms of therapeutic strategy.

Russo P, Fini M, Cesario A.

Curr Pharm Des. 2014;20(38):5919-20. No abstract available.

PMID:
24641221
12.

Thrombophilic mutations as risk factor for retinal vein occlusion: a case-control study.

Russo PD, Damante G, Pasca S, Turello M, Barillari G.

Clin Appl Thromb Hemost. 2015 May;21(4):373-7. doi: 10.1177/1076029614522544.

PMID:
24569626
13.

EGFR-targeted therapy for non-small cell lung cancer: focus on EGFR oncogenic mutation.

Antonicelli A, Cafarotti S, Indini A, Galli A, Russo A, Cesario A, Lococo FM, Russo P, Mainini AF, Bonifati LG, Nosotti M, Santambrogio L, Margaritora S, Granone PM, Dutly AE.

Int J Med Sci. 2013;10(3):320-30. doi: 10.7150/ijms.4609. Review.

14.

Nicotinic receptor and tobacco-related cancer.

Russo P, Cardinale A, Margaritora S, Cesario A.

Life Sci. 2012 Nov 27;91(21-22):1087-92. doi: 10.1016/j.lfs.2012.05.003. Review.

PMID:
22705232
15.

New anticancer drugs from marine cyanobacteria.

Russo P, Cesario A.

Curr Drug Targets. 2012 Jul;13(8):1048-53. Review.

PMID:
22594472
16.

Presentation to the special issue: "α7-nicotinic receptor (α7-nAChR): one target different diseases".

Russo P, Cesario A, Cardinale A.

Curr Drug Targets. 2012 May;13(5):573. No abstract available.

PMID:
22564210
17.

Concluding notes of special issue "α-7 nicotinic receptor (α7-nAChR): one target different diseases".

Russo P, Cesario A, Fini M.

Curr Drug Targets. 2012 May;13(5):726-7. No abstract available.

PMID:
22300041
18.

A new "era" for the α7-nAChR.

Russo P, Cardinale A, Shuller H.

Curr Drug Targets. 2012 May;13(5):721-5.

PMID:
22300040
19.

Is α7-nAChR a possible target for lung cancer and malignant pleural mesothelioma treatment?

Cesario A, Russo P, Nastrucci C, Granone P.

Curr Drug Targets. 2012 May;13(5):688-94.

PMID:
22300036
20.

α7 nAChR in airway respiratory epithelial cells.

Nastrucci C, Russo P.

Curr Drug Targets. 2012 May;13(5):666-70. Review.

PMID:
22300033

Supplemental Content

Loading ...
Support Center